Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Probucol markedly reduces HDL phospholipids and elevated prebeta1-HDL without delayed conversion into alpha-migrating HDL: putative role of angiopoietin-like protein 3 in probucol-induced HDL remodeling.

Miida T, Seino U, Miyazaki O, Hanyu O, Hirayama S, Saito T, Ishikawa Y, Akamatsu S, Nakano T, Nakajima K, Okazaki M, Okada M.

Atherosclerosis. 2008 Oct;200(2):329-35. doi: 10.1016/j.atherosclerosis.2007.12.031. Epub 2008 Feb 14.

PMID:
18279878
2.

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.

Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS, Wahlstrand B, Hedner T, Corella D, Tai ES, Ordovas JM, Berglund G, Vartiainen E, Jousilahti P, Hedblad B, Taskinen MR, Newton-Cheh C, Salomaa V, Peltonen L, Groop L, Altshuler DM, Orho-Melander M.

Nat Genet. 2008 Feb;40(2):189-97. doi: 10.1038/ng.75. Epub 2008 Jan 13. Erratum in: Nat Genet. 2008 Nov;40(11):1384.

3.

Newly identified loci that influence lipid concentrations and risk of coronary artery disease.

Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, Sundvall J, Watanabe RM, Nagaraja R, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Davey-Smith G, Shuldiner AR, Collins R, Bergman RN, Uda M, Tuomilehto J, Cao A, Collins FS, Lakatta E, Lathrop GM, Boehnke M, Schlessinger D, Mohlke KL, Abecasis GR.

Nat Genet. 2008 Feb;40(2):161-9. doi: 10.1038/ng.76. Epub 2008 Jan 13.

4.

Clinical practice. Hypertriglyceridemia.

Brunzell JD.

N Engl J Med. 2007 Sep 6;357(10):1009-17. Review. No abstract available.

PMID:
17804845
5.

Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.

Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A.

JAMA. 2007 Jul 18;298(3):299-308.

PMID:
17635890
6.

Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research., Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, Hughes TE, Groop L, Altshuler D, Almgren P, Florez JC, Meyer J, Ardlie K, Bengtsson Boström K, Isomaa B, Lettre G, Lindblad U, Lyon HN, Melander O, Newton-Cheh C, Nilsson P, Orho-Melander M, Råstam L, Speliotes EK, Taskinen MR, Tuomi T, Guiducci C, Berglund A, Carlson J, Gianniny L, Hackett R, Hall L, Holmkvist J, Laurila E, Sjögren M, Sterner M, Surti A, Svensson M, Svensson M, Tewhey R, Blumenstiel B, Parkin M, Defelice M, Barry R, Brodeur W, Camarata J, Chia N, Fava M, Gibbons J, Handsaker B, Healy C, Nguyen K, Gates C, Sougnez C, Gage D, Nizzari M, Gabriel SB, Chirn GW, Ma Q, Parikh H, Richardson D, Ricke D, Purcell S.

Science. 2007 Jun 1;316(5829):1331-6. Epub 2007 Apr 26.

7.

Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.

Dallinga-Thie GM, van Tol A, Hattori H, van Vark-van der Zee LC, Jansen H, Sijbrands EJ; DALI study group..

Diabetologia. 2006 Jul;49(7):1505-11. Epub 2006 Apr 28.

PMID:
16752169
8.
9.

Identification of four gene variants associated with myocardial infarction.

Shiffman D, Ellis SG, Rowland CM, Malloy MJ, Luke MM, Iakoubova OA, Pullinger CR, Cassano J, Aouizerat BE, Fenwick RG, Reitz RE, Catanese JJ, Leong DU, Zellner C, Sninsky JJ, Topol EJ, Devlin JJ, Kane JP.

Am J Hum Genet. 2005 Oct;77(4):596-605. Epub 2005 Aug 26.

10.

SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.

Wright WT, Young IS, Nicholls DP, Patterson C, Lyttle K, Graham CA.

Atherosclerosis. 2006 Apr;185(2):353-60. Epub 2005 Aug 25.

PMID:
16125709
11.
12.

A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration.

Ishihara M, Kujiraoka T, Iwasaki T, Nagano M, Takano M, Ishii J, Tsuji M, Ide H, Miller IP, Miller NE, Hattori H.

J Lipid Res. 2005 Sep;46(9):2015-22. Epub 2005 Jun 16.

13.

Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism.

Lookene A, Beckstead JA, Nilsson S, Olivecrona G, Ryan RO.

J Biol Chem. 2005 Jul 8;280(27):25383-7. Epub 2005 May 6.

14.

Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.

Merkel M, Loeffler B, Kluger M, Fabig N, Geppert G, Pennacchio LA, Laatsch A, Heeren J.

J Biol Chem. 2005 Jun 3;280(22):21553-60. Epub 2005 Mar 17.

16.

The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

van Dijk KW, Rensen PC, Voshol PJ, Havekes LM.

Curr Opin Lipidol. 2004 Jun;15(3):239-46. Review.

PMID:
15166778
17.

Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.

Mar R, Pajukanta P, Allayee H, Groenendijk M, Dallinga-Thie G, Krauss RM, Sinsheimer JS, Cantor RM, de Bruin TW, Lusis AJ.

Circ Res. 2004 Apr 16;94(7):993-9. Epub 2004 Mar 4.

18.

Association of apolipoprotein A5 variants with LDL particle size and triglyceride in Japanese Americans.

Austin MA, Talmud PJ, Farin FM, Nickerson DA, Edwards KL, Leonetti D, McNeely MJ, Viernes HM, Humphries SE, Fujimoto WY.

Biochim Biophys Acta. 2004 Jan 20;1688(1):1-9.

19.

DETERMINATION OF HEPARIN-INDUCED LIPOPROTEIN LIPASE ACTIVITY IN HUMAN PLASMA.

BOBERG J, CARLSON LA.

Clin Chim Acta. 1964 Nov;10:420-7. No abstract available.

PMID:
14230938
20.

The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

HAVEL RJ, EDER HA, BRAGDON JH.

J Clin Invest. 1955 Sep;34(9):1345-53. No abstract available.

Supplemental Content

Support Center